Catalyst Pharmaceuticals, Inc. Detailed Financials

Full historical quarterly statements

Metric	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Total Revenue	149.4M	152.6M	148.4M	146.6M	141.4M	141.8M	128.7M	122.7M
Cost of Goods Sold	24.2M	26.1M	25.3M	30.0M	17.9M	21.6M	19.3M	15.4M
Gross Profit	125.2M	126.5M	123.1M	116.6M	123.5M	120.2M	109.4M	107.3M
R&D Expenses	2.7M	1.8M	2.7M	4.4M	3.9M	3.8M	3.3M	3.0M
Operating Expenses	52.0M	64.7M	56.8M	50.3M	60.1M	57.3M	58.5M	53.1M
Operating Income	73.2M	61.8M	66.3M	66.3M	63.4M	62.8M	50.9M	54.2M
Other Income / Gains	11.0M	10.1M	4.8M	3.0M	7.9M	11.3M	6.3M	1.5M
Net Income	63.7M	52.7M	52.8M	52.1M	56.7M	55.9M	43.9M	40.8M
EPS (Diluted)	0.52	0.42	0.43	0.43	0.47	0.47	0.37	0.35
Reported Currency	USD	USD	USD	USD	USD	USD	USD	USD
Gross Profit Ratio	0.838	0.829	0.829	0.796	0.873	0.847	0.85	0.874
General And Administrative Expenses	0	19.8M	44.6M	42.2M	44.3M	13.5M	43.4M	14.5M
Selling And Marketing Expenses	0	33.6M	2.9M	3.7M	2.6M	30.7M	2.5M	26.2M
Selling General And Administrative Expenses	49.3M	53.4M	47.5M	45.9M	46.9M	44.2M	45.9M	40.7M
Other Expenses	0	9.5M	6.7M	0	9.3M	9.3M	9.3M	9.3M
Cost And Expenses	76.2M	90.8M	82.1M	80.3M	78.1M	79.0M	77.8M	68.5M
Interest Income	6.2M	0	0	5.9M	5.3M	4.6M	4.5M	3.8M
Interest Expense	0	0	0	0	0	0	0	0
Depreciation And Amortization	9.8M	9.5M	9.4M	9.5M	9.5M	9.5M	0	9.4M
Ebitda	83.1M	71.4M	80.5M	78.8M	72.8M	72.3M	50.9M	63.7M
Ebitdaratio	0.556	0.468	0.542	0.537	0.515	0.51	0.396	0.519
Operating Income Ratio	0.49	0.405	0.447	0.452	0.448	0.443	0.396	0.442
Income Before Tax	84.2M	71.9M	71.0M	69.3M	71.3M	74.2M	57.2M	55.8M
Income Before Tax Ratio	0.564	0.471	0.479	0.473	0.504	0.523	0.445	0.455
Income Tax Expense	20.5M	19.2M	18.3M	17.2M	14.5M	18.2M	13.3M	15.0M
Net Income Ratio	0.427	0.345	0.356	0.356	0.401	0.394	0.341	0.332
Epsdiluted	0.50	0.40	0.42	0.41	0.45	0.44	0.35	0.33
Weighted Average Shs Out	122.3M	122.3M	122.6M	122.2M	121.5M	119.9M	118.9M	118.2M
Weighted Average Shs Out Dil	126.9M	127.3M	127.1M	127.5M	127.0M	126.3M	125.4M	124.7M